生物学杂志 ›› 2019, Vol. 36 ›› Issue (6): 74-.doi: 10.3969/j.issn.2095-1736.2019.06.074

• 综述与专论 • 上一篇    下一篇

苯并咪唑类化合物靶向抗肿瘤作用及其机制研究进展 

  

  1. 江苏师范大学 生命科学学院, 徐州 221116
  • 出版日期:2019-12-18 发布日期:2019-12-12
  • 通讯作者: 张鹏,副教授,主要从事抗肿瘤药物设计与发现,E-mail:zhangpeng@jsnu.edu.cn
  • 作者简介:丁孺孺,硕士研究生,主要从事抗肿瘤药物筛选,E-mail:18361297553@163.com
  • 基金资助:

    江苏省研究生科研创新计划项目(NO.KYCX17-1615)


Advances of benzimidazole derivatives on the function of antitumors and the mechanism 

  1. School of Life Science, Jiangsu Normal University, Xuzhou 221116, China
  • Online:2019-12-18 Published:2019-12-12

摘要:

苯并咪唑由于其优秀的杂环系统在生物医学方面发挥着重要的作用。国内外很多研究者以苯并咪唑为母核合成了许多具有良好生物活性的苯并咪唑类衍生物。通过收集近年来国内外关于合成具有靶向抗肿瘤活性的苯并咪唑类衍生物的文献,对其主要抗肿瘤作用靶点如拓扑异构酶、PARP、微管蛋白、G-四链体DNA以及CK2蛋白激酶进行分类介绍,并对不同作用靶点下的苯并咪唑类衍生物进行构效分析,阐述不同基团的引入对该化合物抗肿瘤活性的影响,如甲基的引入增强化合物的亲脂性从而更好地进入细胞产生更好的抗肿瘤活性,吸电子基团F和Cl的引入增强化合物对细胞的毒性等。旨在为合成新型低毒的苯并咪唑类抗肿瘤药物提供理论基础。


关键词: 苯并咪唑, 靶向抗肿瘤药物, 机制, 构效关系

Abstract:

Benzimidazole plays an important role in biomedicine because of its excellent heterocyclic system. Many researchers all over the world have synthesized many substituted benzimidazoles with multiple biological activities. In this paper, we collected the literatures on the synthesis of benzimidazole derivatives with antitumor activity in recent years. The main anti-tumor targets such as topoisomerase, PARP, tubulin, G-quadruplex DNA and CK2 protein kinase were introduced. Additionally, the structure-activity relationship of benzimidazole derivatives under different targets was carried out. For example, the methyl substituent at benzimidazole ring increased lipophilicity of the studied compounds and enhanced ability of those compounds to intracellular penetration bringing about higher antitumor. Electron withdrawing groups (F, Cl) on the phenyl ring also enhanced antitumor effect. Our aim is to provide a theoretical basis for the synthesis of novel low toxicity benzimidazole antitumor drugs.


Key words: benzimidazole, drug targets, mechanism, structure-activity relationship

中图分类号: